Scales
Scales is an intervention with 8 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
3
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study for Prevent Chronification Migraine Through Prediction of Response to Treatment With Anti-CGRP Antibodies
Sensory Profile of People With High Intellectual Potential (HIP)
Exploratory Study of Sensory Profile and Coping Strategies in Eating Disorders
Tension-Type Headache and Masseter Thickness in Fibromyalgia
Validity and Reliability of the Turkish Version of HAnDE
Clinical Trials (8)
Study for Prevent Chronification Migraine Through Prediction of Response to Treatment With Anti-CGRP Antibodies
Sensory Profile of People With High Intellectual Potential (HIP)
Exploratory Study of Sensory Profile and Coping Strategies in Eating Disorders
Tension-Type Headache and Masseter Thickness in Fibromyalgia
Validity and Reliability of the Turkish Version of HAnDE
Effectiveness of tDCS on Reducing Craving in Patients Practicing Chemsex: a Single-center, Double-blind, Randomized Controlled Pilot Trial
Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.
The Pilot Project Development Of MEdical Rehabilitation System in Russian Federation
All 8 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 8